Waltz Quoted on ROI from Anti-Fraud Efforts Under President Trump
20 March 2017
Bloomberg BNA
Partner Judy Waltz was quoted in a Bloomberg BNA article, “Trump Budget Would Boost Spending to Fight Medicare, Medicaid Fraud,” covering the ideal return on investment from anti-fraud efforts, and the integrity of the Trump administration’s anti-fraud program as a whole.
Waltz explains that the support for program integrity “is because the [Health Care Fraud and Abuse Control] program has been able to demonstrate a good return on investment, both in actual dollars and in the nonquantifiable deterrent side as well.”
She continues to say that, however, “with the administration’s statements about reducing regulatory burdens, there may be less emphasis on fraud, waste and abuse allegations that reflect regulatory noncompliance [in the future].”
Waltz explains that the support for program integrity “is because the [Health Care Fraud and Abuse Control] program has been able to demonstrate a good return on investment, both in actual dollars and in the nonquantifiable deterrent side as well.”
She continues to say that, however, “with the administration’s statements about reducing regulatory burdens, there may be less emphasis on fraud, waste and abuse allegations that reflect regulatory noncompliance [in the future].”
People
Related News
14 March 2025
In the News
Judith Waltz Assesses HHS Plan to Fast-Track Policy
Foley & Lardner LLP partner Judith Waltz commented in the Report on Medicare Compliance article, "HHS May Go Straight to Final Rules, Bypassing Public Comments," published by the Health Care Compliance Association.
14 March 2025
In the News
Lynn Gandhi Shares Insight on Michigan Tax Case
14 March 2025
In the News
Natasha Allen Highlights State Legislative Push on AI
Foley & Lardner LLP partner Natasha Allen commented in the Law360 article, “Looming Virginia AI Bill Likely Just Start Of State Law Flood,” highlighting the growing enthusiasm at the state level to address artificial intelligence.